Recruitment Status

Not yet recruiting clinical trials

Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 10:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

3237

Shown on this page

Current sort

Live official records

Open in full search

Conditions: Diabetic Foot Ulcer
Interventions: Placenta Stem Cells; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Epinephrine, Hypersensitivity, Immediate, Anaphylaxis
Interventions: Epinephrine Nasal Spray, 2.5 mg, Epinephrine Nasal Spray, 5.25 mg; Drug
Lead sponsor: Hikma Pharmaceuticals USA Inc.; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Marlton, New Jersey • Salt Lake City, Utah

Conditions: Wound Heal
Interventions: Amnion Membrane Powder, Standard of Care; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Postoperative Cognitive Complications, Delirium, Perioperative/Postoperative Complications, Brain Injuries, Anesthesia
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Macular Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, Glaucoma
Interventions: Apraclonidine 1.0% ophthalmic solution; Drug
Lead sponsor: Retina Consultants of Delmarva; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Easton, Maryland

Conditions: Type 1 Diabetes Mellitus, Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM), Chronic Kidney Disease, Diabetic Ketoacidosis, Ketones
Interventions: Sotagliflozin initiation; Drug
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: ASCVD
Interventions: Not listed
Lead sponsor: Cardiology Consultants of Philadelphia; Other
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Clearwater, Florida • Jacksonville, Florida • Houma, Louisiana + 2 more

Conditions: Breast-milk
Interventions: breast milk; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 23 Weeks to 28 Weeks
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Anorexia Nervosa
Interventions: Donepezil; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Prediabetes
Interventions: Stelo CGM; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Severe Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Disinformation, Menthol Cigarettes, Flavored Cigars
Interventions: Individual delivery of anti-disinformation messaging, Community delivery of anti-disinformation messaging; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Not yet recruiting clinical trials

Filter and sort this status page

Live official records

Placental Cells for Diabetic Foot Ulcers

Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy Patients

Amnion Membrane Powder Mohs Study

Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery

Iopidine to Decrease Intraocular Pressure Rise After Injections

Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.

Improving Implementation of Guideline-Recommended LDL-C Management in High-Risk Cardiovascular Patients

Breast-milk Enema Administration to Stimulate Passage of Meconium

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

Trial of CGM Technology in Persons Living With Prediabetes

The Systemic Nature of Severe Traumatic Brain Injury

Correcting Disinformation About Menthol Cigarettes and Flavored Cigars